Indeed, IBC is classically more frequently associated with molecular alterations related to chemosensitivity [41]: high proliferation, high grade, HR-negativity, HER2-positivity, TN and HER2+ molecular subtypes, and TP53 mutations. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.